Insurance mandates and trends in infertility treatments

被引:105
作者
Henne, Melinda B. [1 ,2 ]
Bundorf, M. Kate [3 ]
机构
[1] Walter Reed Army Med Ctr, Dept Obstet & Gynecol, Washington, DC 20307 USA
[2] Stanford Univ, Sch Med, Ctr Hlth Policy Primary Care & Outcomes Res, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
基金
美国医疗保健研究与质量局;
关键词
infertility treatment; health insurance mandates; in vitro fertilization outcomes;
D O I
10.1016/j.fertnstert.2007.01.167
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine the relationship between insurance mandates and the utilization and outcomes of assisted reproductive technologies (ART). Design: Using clinic-level data from 1990 to 2001, we examined differences between states with and without insurance mandates in rates of utilization and outcomes of ART using multivariable least squares regression. Setting: National clinic registry data. Patient(s): Clinics performing ART, no patient-level data. Intervention(s): The type of insurance mandate in each state during each year of the study. Main Outcome Measure(s): Cycles per 1,000 women aged 25-44 years, live births per 1,000 cycles, and multiple births per live ART birth. Result(s): Use of ART grew rapidly during the 1990s and grew most quickly in states that adopted comprehensive insurance mandates. Compared with states without mandates, births per cycle were 4% lower and multiples per ART birth were 2% lower in states with comprehensive mandates. Conclusion(s): Comprehensive insurance mandates are associated with greater utilization of ART and lower rates of births per cycle and multiple births per ART birth. Whether the differences in outcomes are due to differences in embryo transfer practices or to patient characteristics is unclear.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 16 条
[1]  
Adashi Eli Y, 2003, Reprod Biomed Online, V7, P515
[2]   Health disparities and infertility: impacts of state-level insurance mandates [J].
Bitler, M ;
Schmidt, L .
FERTILITY AND STERILITY, 2006, 85 (04) :858-865
[3]  
*BUR LAB STAT BUR, CURR POP
[4]  
*CDC, 2004, 2002 ASS REPR TECHN
[5]  
*CDC, ASS REPR TECHN REP
[6]   Cost-effectiveness of in vitro fertilization [J].
Collins, J .
SEMINARS IN REPRODUCTIVE MEDICINE, 2001, 19 (03) :279-289
[7]  
FRITZ MA, 2002, CONTEMP OBSTET GYNEC, V47, P65
[8]   Insurance coverage and outcomes of in vitro fertilization [J].
Jain, T ;
Harlow, BL ;
Hornstein, MD .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (09) :661-666
[9]  
MARTIN JA, 2003, NATL VITAL STAT REP, P52
[10]   THE COST OF A SUCCESSFUL DELIVERY WITH IN-VITRO FERTILIZATION [J].
NEUMANN, PJ ;
GHARIB, SD ;
WEINSTEIN, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (04) :239-243